Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vimirogant in plaque psoriasis
NCT03339999Phase 2Terminated
- Sponsor
- Vitae Pharmaceuticals
- Start
- Nov 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vimirogant in plaque psoriasis, sponsored by Vitae Pharmaceuticals. Started Nov 2017; status: terminated.
02
Drugs
vimirogant
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03339999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339999.